Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/16/2011 | CN101647899B Medicine for treating barrenness of milk cow |
03/16/2011 | CN101647881B Medicine for treating fever of chicken |
03/16/2011 | CN101647865B Externally-applied medicine for treating traumatic injuries |
03/16/2011 | CN101637599B Chinese medicinal composition for removing haemostasis in female genital system |
03/16/2011 | CN101618200B Externally-applied plaster for specially treating cervical spondylosis and preparation method thereof |
03/16/2011 | CN101612291B Medicine composition for treating psoriasis |
03/16/2011 | CN101601850B Lactagogue and health care traditional Chinese medicine for lying-in women |
03/16/2011 | CN101590186B Chinese medicinal composition for thoroughly eliminating hysteromyoma |
03/16/2011 | CN101590185B Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof |
03/16/2011 | CN101537061B Chinese medicine for treating liver cancer |
03/16/2011 | CN101530515B Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |
03/16/2011 | CN101530490B Traditional Chinese medicine for treating bladder cancer |
03/16/2011 | CN101485808B Method for measuring naringin content in preparation for reunion of bone |
03/16/2011 | CN101485778B Capsule prescription containing prepared rehmannia root and oyster and preparation method thereof |
03/16/2011 | CN101485754B Medicament for treating gastropathy and preparation method |
03/16/2011 | CN101485749B Effervescent tablets for women as well as preparation method and application thereof |
03/16/2011 | CN101461916B External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same |
03/16/2011 | CN101444603B Pharmaceutical composition for slimming and preparation method thereof |
03/16/2011 | CN101417021B External traditional Chinese medicine for giving up drug habits and preparation method |
03/16/2011 | CN101361798B Traditional Chinese medicine for treating apoplexia and flaccid paralysis |
03/16/2011 | CN101347606B Chinese medicine plaster for treating rheumatism osteonosus and preparation method |
03/16/2011 | CN101342217B Quick-effective pain relieving traditional Chinese medicine liniment for treating advanced cancer and preparation method thereof |
03/16/2011 | CN101264273B Orally-administered pure Chinese medicine for treating bone fracture and osteosporosis and preparation thereof |
03/16/2011 | CN101264150B Chinese medicinal composition containing radix astragali and preparation thereof |
03/16/2011 | CN101264130B Film coating agent for treating skin ulcer |
03/16/2011 | CN101249231B Medicine composition for treating lithiasis and preparation thereof |
03/16/2011 | CN101167863B Proprietary Chinese medicine for treating diabetes and nephrosis and preparing method thereof |
03/16/2011 | CN101129470B Method of preparing the tablet for hepatitis disease |
03/16/2011 | CN101036732B Chinese medicine preparation for esophagus cancer and its compounding process |
03/15/2011 | US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP) |
03/15/2011 | US7906330 Two cell population comprising chondrocyte precursors and human embryonic stem cells |
03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
03/15/2011 | US7906149 Method for treating allergic dermatitis |
03/15/2011 | US7906110 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
03/15/2011 | CA2494063C Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
03/15/2011 | CA2480708C Method and dietary composition for improving fat digestibility |
03/15/2011 | CA2452005C Inhibition of apoptosis process and improvement of cell performance |
03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
03/15/2011 | CA2202875C Process for purifying factor viii |
03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
03/15/2011 | CA2163517C Surrogate tolerogenesis for the development of tolerance to xenografts |
03/10/2011 | WO2011029007A2 Human lymphoid tissue inducer (lti) cell compositions and methods of use |
03/10/2011 | WO2011028937A1 Extracellular matrix material created using non-thermal irreversible electroporation |
03/10/2011 | WO2011028733A1 Compositions and minimally invasive methods for treating cancer |
03/10/2011 | WO2011028062A2 Composition for increasing height |
03/10/2011 | WO2011027990A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
03/10/2011 | WO2011027875A1 Agent for improving intestinal tract barrier function |
03/10/2011 | WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient |
03/10/2011 | WO2011008348A3 Dual vector for inhibition of human immunodeficiency virus |
03/10/2011 | WO2010115053A9 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells |
03/10/2011 | WO2010114319A3 Composition for bone regeneration |
03/10/2011 | US20110061115 Lung rpogenitor cells, assays, and uses thereof |
03/10/2011 | US20110060412 Tissue Engineered Meniscus Repair Composition |
03/10/2011 | US20110059456 System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells |
03/10/2011 | US20110059184 Medicament for treating parkinson's disease |
03/10/2011 | US20110059182 Spraying device and related method for cell aggregates and cell aggregate suspension thereof |
03/10/2011 | US20110059178 Tissue Engineered Meniscus Repair Composition |
03/10/2011 | US20110059168 Method for correcting intestinal glutamine synthetase deficiency |
03/10/2011 | US20110059165 Seamless alginate capsules |
03/10/2011 | US20110059158 Charged phospholipid compositions and methods for their use |
03/10/2011 | US20110059152 Augmentation of organ function |
03/10/2011 | US20110059134 Prevention of recurrent viral disease |
03/10/2011 | US20110059125 Zwitterionic immunomodulators for the treatment of asthma and allergy |
03/10/2011 | US20110059120 Glucan-based vaccines |
03/10/2011 | US20110059097 MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells |
03/10/2011 | US20110059060 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile |
03/10/2011 | US20110059059 Methods for Treating Ischemic Tissue |
03/10/2011 | US20110059058 Strain of Lactobacillus Rhamnosus |
03/10/2011 | US20110059057 Keratinocytes expressing exogenous angiogenic growth factors |
03/10/2011 | US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins |
03/10/2011 | US20110059055 Treating myelin diseases with optimized cell preparations |
03/10/2011 | US20110059054 Enhanced dendritic cells for cancer immunotherapy |
03/10/2011 | US20110059053 Method of treating biocells |
03/10/2011 | US20110059052 Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose |
03/10/2011 | US20110059051 Molecular Control of Brown Fat Differentiation and Engergy Expenditure |
03/10/2011 | US20110059050 Methods and compositions relating to stem cell transplantation |
03/10/2011 | US20110059049 Poxviral oncolytic vectors |
03/10/2011 | US20110059015 Vaccine |
03/10/2011 | US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity |
03/10/2011 | CA2772076A1 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
03/09/2011 | EP2292778A1 Use of lentiviral triplex forming sequences for nuclear transfer of nucleotide sequences |
03/09/2011 | EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
03/09/2011 | EP2292740A1 Phage of Acinetobacter baumannii |
03/09/2011 | EP2292737A1 Use of adipose tissue-derived stromal stem cells in treating fistula |
03/09/2011 | EP2292735A1 Cell fractions containing cells capable of differentiating into neural cells |
03/09/2011 | EP2292734A1 Hematopoietic cells from human embryonic stem cells |
03/09/2011 | EP2292631A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
03/09/2011 | EP2292278A2 Augmentation of organ function |
03/09/2011 | EP2292264A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
03/09/2011 | EP2292246A1 Recombinant Newcastle Disease Virus |
03/09/2011 | EP2292245A1 Disinfectant composition comprising phage |
03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
03/09/2011 | EP2291521A1 Viral nucleic acid for the treatment of neurodegenerative disorders |
03/09/2011 | EP2291515A2 Methods for propagation of renal precursor cells |
03/09/2011 | EP2291499A1 Krill oil process |
03/09/2011 | EP2291089A1 Bifidobacterium longum and hippocampal bdnf expression |
03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
03/09/2011 | EP1458852B1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
03/09/2011 | EP1385466B1 Oncolytic virus therapy |